Search research articles
Contact Us
Filters
Showing results (421-430 of 616) with videos related to
Page
of 62
Sort By:
Journal of the American College of Cardiology
|
September 1, 2024
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program
Subodh Verma, Javed Butler, Barry A Borlaug, et al.
Circulation Research
|
August 26, 2006
Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate
Chao-Hung Wang, Nicole Anderson, Shu-Hong Li, et al.
The Canadian Journal of Cardiology
|
January 25, 2022
Leaflet Resection vs Preservation for Degenerative Mitral Regurgitation: Functional Outcomes and Mitral Stenosis at 12 Months in a Randomized Trial
Makoto Hibino, Arjun Pandey, Vincent Chan, et al.
Circulation
|
October 26, 2018
Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement
Erwan Salaun, Haïfa Mahjoub, Nicolas Girerd, et al.
The Canadian Journal of Cardiology
|
December 5, 2009
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society
David Fitchett, John Eikelboom, Stephen Fremes, et al.
European Journal of Heart Failure
|
June 6, 2023
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial
Michael Böhm, Javed Butler, Marcin Krawczyk, et al.
Diabetes, Obesity & Metabolism
|
December 15, 2020
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study
Mikhail Kosiborod, Otavio Berwanger, Gary G Koch, et al.
Journal of the American College of Cardiology
|
May 10, 2023
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories
Javed Butler, Milton Packer, Tariq Jamal Siddiqi, et al.
The Canadian Journal of Cardiology
|
October 2, 2018
CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management
G B John Mancini, Alice Y Cheng, Kim Connelly, et al.
Cardiovascular Diabetology
|
August 28, 2024
Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial
Marina Pourafkari, Kim A Connelly, Subodh Verma, et al.
Page
of 62
Search research articles
Search
Showing results (421-430 of 616) with videos related to
Sort By:
Page
of 62
Journal of the American College of Cardiology
|
September 1, 2024
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program
Subodh Verma, Javed Butler, Barry A Borlaug, et al.
Circulation Research
|
August 26, 2006
Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate
Chao-Hung Wang, Nicole Anderson, Shu-Hong Li, et al.
The Canadian Journal of Cardiology
|
January 25, 2022
Leaflet Resection vs Preservation for Degenerative Mitral Regurgitation: Functional Outcomes and Mitral Stenosis at 12 Months in a Randomized Trial
Makoto Hibino, Arjun Pandey, Vincent Chan, et al.
Circulation
|
October 26, 2018
Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement
Erwan Salaun, Haïfa Mahjoub, Nicolas Girerd, et al.
The Canadian Journal of Cardiology
|
December 5, 2009
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society
David Fitchett, John Eikelboom, Stephen Fremes, et al.
European Journal of Heart Failure
|
June 6, 2023
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial
Michael Böhm, Javed Butler, Marcin Krawczyk, et al.
Diabetes, Obesity & Metabolism
|
December 15, 2020
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study
Mikhail Kosiborod, Otavio Berwanger, Gary G Koch, et al.
Journal of the American College of Cardiology
|
May 10, 2023
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories
Javed Butler, Milton Packer, Tariq Jamal Siddiqi, et al.
The Canadian Journal of Cardiology
|
October 2, 2018
CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management
G B John Mancini, Alice Y Cheng, Kim Connelly, et al.
Cardiovascular Diabetology
|
August 28, 2024
Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial
Marina Pourafkari, Kim A Connelly, Subodh Verma, et al.
Page
of 62